Repare Therapeutics | Precision Oncology | Repare Therapeutics ...
Dec 24, 2025 · Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair. For more information, please visit …
Repare Therapeutics | Synthetic Lethality | Press Releases
Jan 16, 2026 · Press releases for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines.
Repare Therapeutics | Precision Oncology | Investor Relations
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by synthetic lethality approach to the discovery and development of novel therapeutics.
Repare Therapeutics Provides Corporate Update and Highlights ...
Jan 8, 2024 · Repare’s platform enables the development of precision therapeutics in patients whose tumors contain one or more genomic alterations identified by SNIPRx® screening, in order to …
Repare Therapeutics Provides Business and Clinical Update and …
Jun 30, 2024 · Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc ...
Jan 16, 2026 · Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s clinical-stage pipeline includes …
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement …
Jul 15, 2025 · Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s clinical-stage pipeline includes RP-3467, a …
Repare Therapeutics Announces Updated Positive Safety and …
Oct 23, 2024 · Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.
R.H.M has served in an advisory/consulting role for IDEAYA Biosciences, Nimbus Therapeutics, and Puretech Health; and has received research funding paid to the institution from Nimbus Therapeutics …
About Repare Therapeutics, Inc. Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of …